Featured Research

from universities, journals, and other organizations

Liver, belly fat may identify high risks of heart disease in obese people

Date:
July 22, 2011
Source:
American Heart Association
Summary:
Increased liver fat and abdominal fat may increase risk of heart disease and other serious health problems, according to researchers. Measuring liver and belly fat may identify obese people at risk of developing abnormal cholesterol. For some obese people, fat is not metabolically detrimental.

Obese people with high levels of abdominal fat and liver fat may face increased risks for heart disease and other serious health problems, according to research published in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

Obesity is commonly associated with heart disease risk and problems called cardiometabolic abnormalities, including insulin resistance, type 2 diabetes, cholesterol disorders, hypertension and gout.

Researchers in Sweden and Finland found that obese people at the highest risk have increased secretion of liver lipids, more abdominal fat and impaired removal of triglycerides from the blood stream. As such, doctors should routinely check obese patients for intra-abdominal obesity and indications of liver fat, researchers said.

"It is important to recognize that measuring abdominal fat and liver fat can identify the patients at high risk for metabolic abnormalities and heart disease," said Jan Boren, M.D., Ph.D., study senior author and professor of molecular and clinical medicine at the University of Gothenburg in Sweden. "Such exams are important because up to 20 percent of the obese appear to be "metabolically normal."

The researchers investigated what makes some obese people develop lipid disorders. They found that liver fat is strongly associated with increased secretion of very-low-density lipoproteins (VLDL), which contain the highest amount of triglycerides. High levels of triglycerides carry an increased risk of metabolic abnormalities and increased risk of heart disease and premature death.

"Increased liver fat is dangerous, as it is linked with many known heart disease risk factors," said Marja-Riitta Taskinen, M.D., Ph.D. study co-author and professor of medicine at the University of Helsinki in Finland. "Lifestyle modifications such as exercise and weight loss can reduce liver fat and the secretion of lipoproteins."

In the study, middle-aged Caucasian Finnish men were divided into three groups: 14 obese men had high triglycerides; 14 obese men had normal triglycerides and 10 men who were not obese and had normal triglycerides served as controls. The obese men's average age was 52 to 55 years. The non-obese men's average age was 48 years.

Researchers used proton magnetic resonance spectroscopy to measure liver fat, while subcutaneous abdominal and visceral fat were measured by magnetic resonance imaging.

The results showed that triglyceride levels in the obese men were higher as a result of the increased secretion coupled with severely impaired clearance of triglyceride-rich VLDL particles. Researchers also found:

  • The obese men with elevated triglycerides had a liver fat content of 13 percent.
  • The obese men with normal triglycerides had a 6.9 percent liver fat content.
  • The non-obese men had a 2.9 percent liver fat content.

Researchers plan to conduct a similar study in women.

Other co-authors are: Martin Adiels, Ph.D.; Jukka Westerbacka, M.D., Ph.D.; Sanni Soderllund, M.D.; Juhani Kahri, M.D., Ph.D.; Nina Lundbom, M.D., Ph.D.; Jesper Lundbom, M.S.; Antti Hakkaarain, B.S.; Swen-Olof Olofsson, M.D., Ph.D. and Marja Ortho-Melander, Ph.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marja-Riitta Taskinen, Martin Adiels, Jukka Westerbacka, Sanni Sφderlund, Juhani Kahri, Nina Lundbom, Jesper Lundbom, Antti Hakkarainen, Sven-Olof Olofsson, Marju Orho-Melander, Jan Borιn. Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects. Arteriosclerosis, Thrombosis and Vascular Biology, 2011; DOI: 10.1161/ATVBAHA.111.224808

Cite This Page:

American Heart Association. "Liver, belly fat may identify high risks of heart disease in obese people." ScienceDaily. ScienceDaily, 22 July 2011. <www.sciencedaily.com/releases/2011/07/110721163021.htm>.
American Heart Association. (2011, July 22). Liver, belly fat may identify high risks of heart disease in obese people. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/07/110721163021.htm
American Heart Association. "Liver, belly fat may identify high risks of heart disease in obese people." ScienceDaily. www.sciencedaily.com/releases/2011/07/110721163021.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins